Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05487417Phase 4Recruiting

Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy

Role: collaborator

NCT05956847Recruiting

The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric

Role: collaborator

NCT02982655Not ApplicableCompleted

Controlling Hypertension After Severe Cerebrovascular Event

Role: collaborator

All 3 trials loaded